ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 683

Risk Factors of Uveitis in Ankylosing Spondylitis

Feng Wang1, Qin Xue2, Li Sun3 and Niansong Wang4, 1Nephrology and Rheumatology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China, 2Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China, 3Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, China, 4Shanghai Jiao Tong University Affiliated Sixth People's Hospital, shanghai, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), arthritis and uveitis, Hip, OA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Uveitis is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS).The prevalence and characteristics of uveitis in AS have been studied in previous literatures while its associated risk factors have not been clarified. Therefore,this study analysed the risk factors of uveitis in patients with AS.

Methods:

A total of 390 patients with AS who fulfilled the modified New York criteria were enrolled from January to December in 2015.The history of uveitis was accepted only if diagnosed by ophthalmologists.The medical records of the patients were retrospectively reviewed and associated information was collected,such as disease duration,HLA-B27 and the number of peripheral arthritis.Hip-joint lesion was identified by imaging examination.Meanwhile, biochemical examinations were performed to determine the patient’s physical function.

Results: Of 390 patients with AS (80.5% male, mean age 33.3 years), 38 (9.7%) had experienced one or more episodes of uveitis. The incidence rate for hip-joint lesion was obviously higher for patients with uveitis than the non-uveitis group (44.7% vs 22.2%; P<0.01). The number of peripheral arthritis was also larger for the uveitis group than non-uveitis group (2.18±0.23 vs 0.55±0.04; P<0.001). Meanwhile, patients with uveitis had a significantly higher level of antistreptolysin O (ASO) and circulating immune complex (CIC) than those without (P<0.05 and P<0.0001, respectively). However, there were no significant differences in disease duration, HLA-B27, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) between the two groups. Binary logistic regression results showed that ASO (OR=12.2, 95% CI:3.6-41.3, P<0.01) and the number of peripheral arthritis (OR=4.1, 95%CI:2.6-6.3, P<0.01) are significantly associated with uveitis in AS.

Conclusion: This study provides some evidence that hip-joint lesion, the number of peripheral arthritis, ASO and CIC may be associated with higher rates of uveitis in AS. The results of this comprehensive analysis suggest that the possible occurrence of uveitis in AS should not be neglected if the patients have those concomitant risk factors.


Disclosure: F. Wang, None; Q. Xue, None; L. Sun, None; N. Wang, None.

To cite this abstract in AMA style:

Wang F, Xue Q, Sun L, Wang N. Risk Factors of Uveitis in Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/risk-factors-of-uveitis-in-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-of-uveitis-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology